Hannover, Germany

Hendrikus Antonius Cornelis Bakker


Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 138(Granted Patents)


Company Filing History:


Years Active: 2009-2016

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Hendrikus Antonius Cornelis Bakker

Introduction

Hendrikus Antonius Cornelis Bakker is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of glycoprotein processing in transgenic plants. With a total of nine patents to his name, Bakker's work has advanced the production of recombinant biopharmaceutical proteins.

Latest Patents

One of his latest patents is focused on GNTIII expression in plants. This invention relates to using transgenic plants as cost-efficient and contamination-safe factories for producing recombinant biopharmaceutical proteins. The invention provides a plant that includes a functional mammalian enzyme, specifically mammalian GnTIII, which is typically absent in plants. Additionally, this plant comprises at least a second mammalian protein or functional fragment that is also not normally present in plants. Another significant patent by Bakker is directed towards optimizing glycan processing in organisms, particularly in plants. This invention aims to produce glycoproteins with complex type bi-antennary glycans, which contain galactose residues on both arms while minimizing xylose and fucose content.

Career Highlights

Throughout his career, Bakker has worked with various organizations, including the Agricultural Research Institute and Plant Research International B.V. His innovative work has positioned him as a key figure in the field of plant biotechnology.

Collaborations

Bakker has collaborated with notable colleagues such as Hendrik Jan Bosch and Dionisius Elisabeth Antonius Florack. These partnerships have further enhanced his research and contributions to the field.

Conclusion

Hendrikus Antonius Cornelis Bakker's innovative work in glycoprotein processing has made a significant impact on the production of biopharmaceuticals. His patents reflect a commitment to advancing biotechnology through transgenic plants.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…